Jenny Mattsson (Former)

1 – 6 of 6

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/je3265ma?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2024
Mark Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells
Ajore, Ram ^LU ; Mattsson, Jenny ^LU ; Pertesi, Maroulio ^LU ; Ekdahl, Ludvig ^LU ; Ali, Zain ^LU ; Hansson, Markus ^LU and Nilsson, Björn ^LU (2024) In Blood Cancer Journal 14(1).
- Contribution to journal › Debate/Note/Editorial
2023
Mark Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens
Mattsson, Jenny ^LU ; Ljungars, Anne ^LU ; Carlsson, Anders ; Svensson, Carolin ; Nilsson, Björn ^LU ; Ohlin, Mats ^LU and Frendéus, Björn (2023) In Cell reports methods 3(5).
- Contribution to journal › Article
Mark New methods for phenotypic antibody discovery
Mattsson, Jenny ^LU (2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
2021
Mark Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
Mattsson, Jenny ^LU ; Ekdahl, Ludvig ^LU ; Junghus, Fredrik ^LU ; Ajore, Ram ^LU ; Erlandsson, Eva ^LU ; Niroula, Abhishek ^LU ; Pertesi, Maroulio ^LU ; Frendéus, Björn ^LU ; Teige, Ingrid ^LU and Nilsson, Björn ^LU (2021) In Nature Communications 12. p.1-8
- Contribution to journal › Article
2018
Mark A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
Ljungars, A. ^LU ; Mårtensson, L. ^LU ; Mattsson, Jenny ^LU ; Kovacek, M. ^LU ; Sundberg, A. ; Tornberg, Ulla-Carin ; Jansson, B. ^LU ; Persson, N. ; Emruli, V. Kuci ^LU and Ek, S. ^LU , et al. (2018) In JCO Precision Oncology 2(1).
- Contribution to journal › Article
2015
Mark Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
Roghanian, Ali ; Teige, Ingrid ^LU ; Mårtensson, Linda ^LU ; Cox, Kerry L ; Kovacek, Mathilda ^LU ; Ljungars, Anne ; Mattson, Jenny ^LU ; Sundberg, Annika ; Vaughan, Andrew T and Shah, Vallari , et al. (2015) In Cancer Cell 27(4). p.473-488
- Contribution to journal › Article